BioHealth News
Solaxa Announces Phase 3 Clinical Trial for Spinocerebellar Ataxia Type 27B
Bethesda, MD — March 28, 2025 – Solaxa Inc., a biopharmaceutical public benefit corporation focused on rare neurological conditions, has announced plans to conduct a registrational clinical…
Read MoreSecretome Therapeutics Begins First Trial of STM-01 for Heart Failure
PLANO, Texas & BALTIMORE--(BUSINESS WIRE)--Secretome Therapeutics, a clinical-stage biotechnology company developing novel therapies derived from neonatal cardiac progenitor cells (nCPC), today announced dosing of…
Read MoreATCC Appoints Dr. Ruth Cheng as New President and Chief Executive Officer
Ruth R. Cheng, PhD, succeeds Raymond H. Cypess, DVM, PhD, who will remain on the Board of Directors as chairman Dr. Cheng is an…
Read MoreMaryland Commerce: Japanese quantum company lays down roots in Maryland
NanoQT, a Tokyo-based quantum computing company, recently announced its expansion into Maryland, with the intent to strengthen the company’s research and development capabilities and…
Read MoreFast Company Recognizes GeneDx as One of the World’s Most Innovative Companies
GeneDx recognized for its innovative approach to accelerating genetic diagnosis and transforming the future of healthcare by ending the diagnostic odyssey GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx…
Read MoreWelldoc Achieves 50+ Patents, Unveiling “CGM-GPT” for Advanced Glucose Prediction
Digital Health Leader's Innovation in Real-Time Sensor-Based AI Sets New Standards for Personalized Cardiometabolic Care COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a digital health leader revolutionizing cardiometabolic…
Read MoreGovernor Glenn Youngkin Announces Luna Labs to Expand Research and Development Operations in Charlottesville
Technology development company will invest $200,000 and create 20 new jobs RICHMOND, VA — Governor Glenn Youngkin today announced that Luna Labs USA, LLC, a…
Read MoreSapio Sciences: Seamless AI-Native Drug Discovery with NVIDIA BioNeMo
BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform. This…
Read MoreBioPharmaDive: AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal
The British drugmaker is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating cancer as well…
Read MorePhlow Corp. Achieves Key Milestone Toward Full Epinephrine Production — Made in America
Validation Completed for a Novel, Cost-Competitive Epinephrine Active Pharmaceutical Ingredient Process, Drug Master File Successfully Filed Richmond, Virginia, March 17, 2025 (GLOBE NEWSWIRE) --…
Read MoreThe Economic Power of NIH Grants: Why Sustained Investment Matters
The National Institutes of Health (NIH) is vital in driving scientific discovery and economic growth across the United States. Recent reports from United for…
Read MoreMotivity Secures $27M Investment to Scale ABA Tech with NIH Entrepreneur in Residence Support
HONOLULU, HI, Mar. 12, 2025 – Motivity, a leading provider of clinical SaaS solutions for Applied Behavior Analysis (ABA) providers who treat children with…
Read MoreWBJ: This Md. biotech wants to get a cancer treatment to patients. It just tapped an industry outsider as co-CEO
By Sara Gilgore – Staff Reporter, Washington Business Journal -Mar 12, 2025 - Gaithersburg’s Shuttle Pharmaceuticals Holdings Inc. (NASDAQ: SHPH) has brought in a…
Read MoreCEL-SCI’s Head and Neck Cancer Study Clears FDA Review, Eyes Commercialization Partners
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today announced it received comments from the U.S. Food and Drug Administration (FDA) on the confirmatory Registration…
Read MoreGain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease
BETHESDA, Md., March 14, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery…
Read More